DexCom, Inc.

85
Strong Buy
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2521311074
USD
66.84
0.9 (1.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
DexCom, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,088.00
709.00
710.00
390.00
256.00
225.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
103.00
108.00
3.00
26.00
-132.00
-20.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,440.00
989.00
748.00
669.00
442.00
475.00
Cash Flow from Investing Activities
536.00
-207.00
-507.00
-521.00
-216.00
-1,018.00
Cash Flow from Financing Activities
-1,686.00
-734.00
-318.00
-552.00
10.00
912.00
Net Cash Inflow / Outflow
311.00
39.00
-75.00
-410.00
235.00
371.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
21.00
-7.00
1.00
-5.00
-1.00
2.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of DexCom, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
1088.4
1272.9
-184.00
-14.49%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
103.4
154.6
-51.00
-33.12%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1440.7
1595.2
-155.00
-9.69%
Cash Flow from Investing Activities
536
-946.6
1,482.00
156.62%
Cash Flow from Financing Activities
-1686.4
-723.1
-963.00
-133.22%
Net Cash Inflow / Outflow
311.8
-119.3
430.00
361.36%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
21.5
-44.8
65.00
147.99%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 45.60% vs 32.20% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
1,440.70
989.50
45.60%